Video

Unlocking AI's Potential In Cell Therapy Through Robust Data

Source: Cell & Gene

In this final segment of Cell & Gene Live, "Building Smarter Cell Therapies with AI and Synthetic Biology," Senti Biosciences' Tim Lu, M.D., Ph.D., and Claire Aldridge, Ph.D., emphasized that high-quality, diverse data infrastructure, spanning successes, failures, metadata, and experimental context, is foundational for AI and synthetic biology to drive CGTs from discovery to clinic.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)